Regeneron Pharmaceuticals has an Enterprise Value (EV) of 77.08B.
5.43
14.49
17.44
21.03
Financial Position
The company has a current ratio of 4.73,
with a Debt / Equity ratio of 0.09.
4.73
3.95
0.09
0.51
0.74
75.61
Financial Efficiency
Return on Equity is 15.03% and Return on Invested Capital is 11.39%.
15.03%
11.69%
11.39%
$936.93K
$291.11K
15,158
0.38
0.79
Taxes
367.3M
7.68%
Stock Price Statistics
The stock price has increased by -49.33% in the
last 52 weeks. The beta is 0.35, so Regeneron Pharmaceuticals's
price volatility has been higher than the market average.
0.35
-49.33%
560.96
626.69
51.26
1,022,070
Income Statement
In the last 12 months, Regeneron Pharmaceuticals had revenue of 14.2B
and earned 4.41B
in profits. Earnings per share was 40.9.